Cynomolgus / Rhesus macaque 4-1BB / TNFRSF9 Protein, His Tag, low endotoxin (MALS verified)

사용자 리뷰
제품 번호/규격
가격
수량
41B-C52H4-100ug
$415.00
41B-C52H4-1mg (500ug X 2)
$2695.00
ETA of in-stock products:2 business days
총 항목 수 제품 금액$ 0

제품 세부정보

  • Synonym

    TNFRSF9, 4-1BB, CD137, CDw137, ILA

  • Source

    Cynomolgus / Rhesus macaque 4-1BB, His Tag (41B-C52H4) is expressed from human 293 cells (HEK293). It contains AA Leu 24 - Gln 186 (Accession # XP_005544945.1). In the region Leu 24 - Gln 186, the AA sequence of Cynomolgus and Rhesus macaque 4-1BB are homologus.

    Predicted N-terminus: Leu 24

    Request for sequence

  • Molecular Characterization

    4-1BB Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a polyhistidine tag at the C-terminus.

    The protein has a calculated MW of 19.2 kDa. The protein migrates as 30-40 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Endotoxin

    Less than 0.01 EU per μg by the LAL method / rFC method.

  • Purity

    >90% as determined by SDS-PAGE.

    >95% as determined by SEC-MALS.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

고객님도 확인한 상품

데이터 표시

  • SDS-PAGE

    4-1BB SDS-PAGE

    Cynomolgus / Rhesus macaque 4-1BB, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90% (With Star Ribbon Pre-stained Protein Marker).

  • SEC-MALS

    4-1BB SEC-MALS

    The purity of Cynomolgus / Rhesus macaque 4-1BB, His Tag (Cat. No. 41B-C52H4) is more than 95% and the molecular weight of this protein is around 25-35 kDa verified by SEC-MALS.

    Report
  • Bioactivity-ELISA

     4-1BB ELISA

    Immobilized Cynomolgus / Rhesus macaque 4-1BB, His Tag (Cat. No. 41B-C52H4) at 1 μg/mL (100 μL/well) can bind Human 4‑1BB Ligand, Fc Tag with a linear range of 0.05-0.5 ng/mL (QC tested).

    Protocol
  • Bridging ELISA

     4-1BB BRIDGING ELISA

    Validated with Bispecific Antibody.
    Immobilized Cynomolgus / Rhesus macaque 4-1BB, His Tag (Cat. No. 41B-C52H4) at 1 μg/mL, add increasing concentrations of Acasunlimab and then add Biotinylated Cynomolgus / Rhesus macaque PD-L1, His, Avitag (Cat. No. PDL-C82E8) at 0.2 μg/mL. Detection was performed using HRP-conjugated streptavidin with sensitivity of 0.15 ng/mL (Routinely tested).

  • Bioactivity-BLI

     4-1BB BLI

    Loaded Human 4-1BB Ligand (71-254), Fc Tag (active trimer) (MALS verified) on Protein A Biosensor, can bind Cynomolgus / Rhesus macaque 4-1BB, His Tag (Cat. No. 41B-C52H4) with an affinity constant of 69.8 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

    Protocol

사용자 리뷰
댓글 남기기

배경 소개

4-1BB is also known as CD137, tumor necrosis factor receptor superfamily member 9 (TNFRSF9), induced by lymphocyte activation (ILA), is a co-stimulatory molecule of the tumor necrosis factor (TNF) receptor superfamily. CD137 can be expressed by activated T cells, but to a larger extent on CD8 than on CD4 T cells. In addition, CD137 expression is found on dendritic cells, follicular dendritic cells, natural killer cells, granulocytes and cells of blood vessel walls at sites of inflammation. The best characterized activity of CD137 is its costimulatory activity for activated T cells. Crosslinking of CD137 enhances T cell proliferation, IL-2 secretion survival and cytolytic activity. Further, it can enhance immune activity to eliminate tumors in mice. CD137 can enhance activation-induced T cell apoptosis when triggered by engagement of the TCR/CD3 complex. In addition, 4-1BB/4-1BBL co-stimulatory pathway has been shown to augment secondary CTL responses to several viruses, and meanwhile augment anti-tumor immunity. 4-1BB thus is a promising candidate for immunotherapy of human cancer. CD137 has been shown to interact with TRAF2.

프론티어 진행

 
의약품 개발 진행
  • 영어 이름:

    Tumor necrosis factor receptor superfamily member 9

  • 카테고리:

  • 상장 의약품 수:

    0 상세

  • 임상 의약품 수:

    77 상세

  • 최고 개발 단계:

    Phase 3 Clinical

연락하기
신약 후보물질 라이선싱
더 많이 알아보기
  • 기본 제품 정보
  • 제품 세부정보
  • 고객님도 확인한 상품
  • 데이터 표시
  • 사용자 리뷰
  • 배경
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호